Original Articles
Vol. 21 No. 4 (2025)
Hepatic damage associated with dengue infection: insights from the emergency department of a tertiary care centre
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 23 July 2025
Accepted: 6 October 2025
Accepted: 6 October 2025
279
Views
109
Downloads
Authors
Liver involvement is a common but variable manifestation of dengue virus infection. This study aimed to evaluate the clinical and biochemical spectrum of dengue hepatitis and its correlation with disease severity in patients presenting to a tertiary care center. A retrospective cross-sectional study was conducted at a tertiary care center from July 2024 to December 2024, including 130 adult patients with laboratory-confirmed dengue infection. Dengue hepatitis was categorized as mild, moderate, or severe based on serum transaminase levels. Disease severity was assessed according to both the World Health Organization (WHO) 1997 and WHO 2009 classification criteria. Laboratory parameters were analyzed in relation to hepatitis severity. Among the 130 patients, 113 (87%) had elevated liver enzymes. Aspartate Aminotransferase Levels (AST) were consistently higher than Alanine Aminotransferase (ALT). Severe dengue hepatitis was significantly associated with WHO 2009 disease severity classification (p<0.001). Total bilirubin levels were significantly elevated in patients with more severe hepatitis, while no significant correlation was observed between platelet count and hepatitis severity. Patients presenting with warning signs and severe dengue had higher frequencies of moderate-to-severe hepatitis. We conclude that hepatic involvement in dengue infection is common and correlates with disease severity. Elevated transaminases, particularly AST, and rising bilirubin levels may serve as early markers of severe dengue. Integration of liver function monitoring into clinical assessment protocols is essential for the timely management of dengue hepatitis.
Downloads
Download data is not yet available.
Citations
1. Guzman MG, Halstead SB, Artsob H, et al. Dengue: a continuing global threat. Nat Rev Microbiol 2010;8:S7–16 DOI: https://doi.org/10.1038/nrmicro2460
2. Zeng Z, Zhan J, Chen L, et al. Global, regional, and national dengue burden from 1990 to 2017: A systematic analysis based on the global burden of disease study 2017. EClinicalMedicine 2021;32:100712. DOI: https://doi.org/10.1016/j.eclinm.2020.100712
3. Messina JP, Brady OJ, Scott TW, et al. Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol 2014;22:138-46. DOI: https://doi.org/10.1016/j.tim.2013.12.011
4. Messina JP, Brady OJ, Golding N, et al. The current and future global distribution and population at risk of dengue. Nature Microbiol 2019;4:1508-15. DOI: https://doi.org/10.1038/s41564-019-0476-8
5. Alagarasu K, Patil JA, Kakade MB, et al. Serotype and genotype diversity of dengue viruses circulating in India: a multi-centre retrospective study involving the Virus Research Diagnostic Laboratory Network in 2018. Int J Infect Dis 2021;111:242-52. DOI: https://doi.org/10.1016/j.ijid.2021.08.045
6. Agarwal A, Ganvir R, Kale D, et al. Continued dominance of dengue virus serotype 2 during the recent Central India outbreaks (2019-2021) with evidence of genetic divergence. Pathogens Global Health 2024;118:109-19. DOI: https://doi.org/10.1080/20477724.2023.2246712
7. Torres-Flores JM, Reyes-Sandoval A, Salazar MI. Dengue vaccines: an update. Biodrugs 2022;36:325. DOI: https://doi.org/10.1007/s40259-022-00531-z
8. Islam MT, Quispe C, Herrera-Bravo J, et al. Production, transmission, pathogenesis, and control of dengue virus: a literature‐based undivided perspective. BioMed Res Int 2021;2021:4224816. DOI: https://doi.org/10.1155/2021/4224816
9. World Health Organization, Special Programme for Research, Training in Tropical Diseases, World Health Organization. Department of Control of Neglected Tropical Diseases, World Health Organization. Epidemic, Pandemic Alert. Dengue: guidelines for diagnosis, treatment, prevention and control. World Health Organization; 2009.
10. Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 2009;22:564-81. DOI: https://doi.org/10.1128/CMR.00035-09
11. Moragas LJ, Alves FD, Oliveira LD, et al. Liver immunopathogenesis in fatal cases of dengue in children: detection of viral antigen, cytokine profile and inflammatory mediators. Front Immunol 2023;14:1215730. DOI: https://doi.org/10.3389/fimmu.2023.1215730
12. Leowattana W, Leowattana T. Dengue hemorrhagic fever and the liver. World J Hepatol 2021;13:1968.
13. Zheng W, Yan Q, Li Z, et al. Liver transcriptomics reveals features of the host response in a mouse model of dengue virus infection. Front Immunol 2022;13:892469. DOI: https://doi.org/10.3389/fimmu.2022.892469
14. Jafri AD, Dhar SK, Maiti S, et al. Impact of diabetes on dengue - a comparative study of clinical and inflammatory variables in patients with and without diabetes. Eur J Clin Exp Med. 2025;23(3):701–708. doi: 10.15584/ejcem.2025.3.28. DOI: https://doi.org/10.15584/ejcem.2025.3.28
15. Ravilla S, Padmaprakash KV, Arun N, Kanth R. Liver Function Test Abnormalities: Do They Correlate with Severity in Dengue Infection? An Indian Perspective. J Marine Med Soc 2023;25:48-52. DOI: https://doi.org/10.4103/jmms.jmms_88_22
16. Fernando S, Wijewickrama A, Gomes L, et al. Patterns and causes of liver involvement in acute dengue infection. BMC Infect Dis 2016;16:1-9. DOI: https://doi.org/10.1186/s12879-016-1656-2
17. Dissanayake HA, Seneviratne SL. Liver involvement in dengue viral infections. Rev Med Virol 2018;28:e1971. DOI: https://doi.org/10.1002/rmv.1971
18. Leowattana W, Leowattana T. Dengue hemorrhagic fever and the liver. World J Hepatol 2021;13:1968. DOI: https://doi.org/10.4254/wjh.v13.i12.1968
19. Aye KS, Charngkaew K, Win N, et al. Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. Human Pathology 2014;45:1221-33. DOI: https://doi.org/10.1016/j.humpath.2014.01.022
20. Kumar A, Arora A. Liver involvement in common febrile illnesses. Curr Med Res Pract 2018;8:170-6. DOI: https://doi.org/10.1016/j.cmrp.2018.08.001
21. Narasimhan D, Ponnusamy P, Sathish M. Analysis of liver function tests in dengue fever. Int J Adv Med. 2018;5(1):47-49. doi:10.18203/2349-3933.ijam20175500. DOI: https://doi.org/10.18203/2349-3933.ijam20175500
22. Seneviratne SL, Malavige GN, De Silva HJ. Pathogenesis of liver involvement during dengue viral infections. Trans Royal Soc Trop Med Hygiene 2006;100:608-14. DOI: https://doi.org/10.1016/j.trstmh.2005.10.007
23. Bhushan D, Kumar R. Clinical profile, hepatic dysfunctions, and outcome of dengue patients in a tertiary care hospital of Eastern India. J Assoc Physicians India 2018;66:52-4.
24. Souza LJ, Alves JG, Nogueira RM, et al. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases. Braz J Infect Dis 2004;8:156–63. DOI: https://doi.org/10.1590/S1413-86702004000200006
25. Mohan B, Patwari AK, Anand VK. Hepatic dysfunction in childhood dengue infection. J Trop Pediatr. 2000;46(1):40-43. doi:10.1093/tropej/46.1.40. DOI: https://doi.org/10.1093/tropej/46.1.40
26. Kumar A, Arora A. Non-viral infective and non-infective mimics of hepatitis. Viral Hepatitis in Indian Subcontinent. 1st ed. Indian College of Physicians, Mumbai: India. 2017:91-118.
27. Chia PY, Thein TL, Ong SW, et al. Severe dengue and liver involvement: an overview and review of the literature. Expert Rev Anti-Infective Ther 2020;18:181-9. DOI: https://doi.org/10.1080/14787210.2020.1720652
28. Priyangika DK, Premawansa G, Adikari M, et al. Predictive value of hepatic transaminases during febrile phase as a predictor of a severe form of Dengue:Analysis of adult Dengue patients from a tertiary care setting of Sri Lanka. BMC Res Notes 2021;14:251. DOI: https://doi.org/10.1186/s13104-021-05670-0
29. Shivkar RR, Padwal MK, Vaidya A. Correlation of liver transaminases with platelet count in dengue patients from tertiary care hospital in Western India. Int J Curr Res Rev 2018;10:15-22.
30. Lee LK, Gan VC, Lee VJ, Tan AS, Leo YS, Lye DC. Clinical relevance and discriminatory value of elevated liver aminotransferase levels for dengue severity. Plos Neglected Trop Dis 2012;6:e1676. DOI: https://doi.org/10.1371/journal.pntd.0001676
31. Pandejpong D, Saengsuri P, Rattarittamrong R, et al. Is excessive acetaminophen intake associated with transaminitis in adult patients with dengue fever? Intern Med J 2015;45:653-8. DOI: https://doi.org/10.1111/imj.12756
32. Vasikasin V, Rojdumrongrattana T, Chuerboonchai W, et al. Effect of standard dose paracetamol versus placebo as antipyretic therapy on liver injury in adult dengue infection: a multicentre randomised controlled trial. Lancet Global Health 2019;7:e664-70. DOI: https://doi.org/10.1016/S2214-109X(19)30032-4
33. Syed AA, Aslam F, Hakeem H, et al. Frequency of worsening liver function in severe dengue hepatitis patients receiving paracetamol: A retrospective analysis of hospital data. JPMA. J Pakistan Med Assoc 2017;67:400.
34. Wendon J, Cordoba J, Dhawan A, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017;66:1047-81. DOI: https://doi.org/10.1016/j.jhep.2016.12.003
How to Cite
Hepatic damage associated with dengue infection: insights from the emergency department of a tertiary care centre. (2025). Emergency Care Journal, 21(4). https://doi.org/10.4081/ecj.2025.14168
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
